Template:Spinal Muscular Atrophy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 154: | Line 154: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Spinal | [[Spinal muscular atrophy outcome measures|Outcome measures]] | ||
|- | |- | ||
! | ! | ||
Line 160: | Line 160: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Spinal | [[Spinal muscular atrophy therapeutics development|Therapeutics development]] | ||
|- | |- | ||
! | ! |
Revision as of 17:17, 26 June 2011
Spinal Muscular Atrophy Microchapters |
Spinal Muscular Atrophy Resources |
---|
Ongoing Trials on Spinal Muscular Atrophy at Clinical Trials.gov |
US National Guidelines Clearinghouse on Spinal Muscular Atrophy |
Risk calculators and risk factors for Spinal Muscular Atrophy |